| 2024-04-15 16:39 | CC:TH | Theratechnologies Inc (2) | 1.80 | News Release200 | Theratechnologies mails proxy circular for May 9 AGM |
| 2024-04-10 11:45 | CC:TH | Theratechnologies Inc (2) | 2.09 | News Release200 | Theratechnologies loses $4.48-million (U.S.) in Q1 |
| 2024-04-10 07:54 | CC:TH | Theratechnologies Inc (2) | 2.09 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2024-04-10 07:54 | CC:TH | Theratechnologies Inc (2) | 2.09 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-04-10 07:54 | CC:TH | Theratechnologies Inc (2) | 2.09 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2024-04-08 16:43 | CC:TH | Theratechnologies Inc (2) | 1.93 | News Release200 | Theratechnologies presents preclinical data on SORT1+ |
| 2024-04-05 11:28 | CC:TH | Theratechnologies Inc (2) | 2.06 | News Release200 | Theratechnologies appoints Tea as director |
| 2024-04-03 11:00 | CC:TH | Theratechnologies Inc (2) | 2.16 | News Release200 | Theratechnologies to release Q1 2024 results April 10 |
| 2024-03-22 10:56 | CC:TH | Theratechnologies Inc (2) | 1.70 | News Release200 | Theratechnologies to cut preclinical cancer research |
| 2024-03-21 20:06 | CC:TH | Theratechnologies Inc (2) | 1.70 | News Release200 | Theratechnologies appoints Zwick as director |
| 2024-03-21 10:52 | CC:TH | Theratechnologies Inc (2) | 1.65 | News Release200 | Theratechnologies increases dose level in phase 1 trial |
| 2024-02-29 16:38 | CC:TH | Theratechnologies Inc (2) | 2.01 | News Release200 | Theratechnologies director Trudeau resigns |
| 2024-02-27 08:30 | CC:TH | Theratechnologies Inc (2) | 2.20 | News Release200 | Theratechnologies gets refusal-to-file letter from FDA |
| 2024-02-21 11:32 | CC:TH | Theratechnologies Inc (2) | 2.27 | News Release200 | Theratechnologies loses $23.95M (U.S.) in fiscal 2023 |
| 2024-02-21 08:41 | CC:TH | Theratechnologies Inc (2) | 2.27 | SEDAR Annual Report803 | SEDAR Annual Report |
| 2024-02-21 08:30 | CC:TH | Theratechnologies Inc (2) | 2.27 | SEDAR MD & A815 | SEDAR MD & A |
| 2024-02-21 08:30 | CC:TH | Theratechnologies Inc (2) | 2.27 | SEDAR MD & A815 | SEDAR MD & A |
| 2024-02-21 08:24 | CC:TH | Theratechnologies Inc (2) | 2.27 | SEDAR Audited Annual Financial Statements804 | SEDAR Audited Annual Financial Statements |
| 2024-02-20 12:07 | CC:TH | Theratechnologies Inc (2) | 2.23 | News Release200 | Theratechnologies publishes journal article on TH1902 |
| 2024-02-15 11:25 | CC:TH | Theratechnologies Inc (2) | 2.28 | News Release200 | Theratechnologies enrolls six patients in TH1902 trial |
| 2024-02-06 11:32 | CC:TH | Theratechnologies Inc (2) | 2.13 | News Release200 | Theratechnologies to release 2023 results Feb. 21 |
| 2024-01-24 09:12 | CC:TH | Theratechnologies Inc (2) | 2.33 | News Release200 | Theratechnologies says FDA wants more tesamorelin info |
| 2024-01-23 11:19 | CC:TH | Theratechnologies Inc (2) | 2.48 | News Release200 | Theratechnologies's tesamorelin sBLA still under review |
| 2024-01-02 10:03 | CC:TH | Theratechnologies Inc (2) | 2.25 | News Release200 | Theratechnologies files sBLA for intramuscular Trogarzo |
| 2023-12-21 17:29 | CC:TH | Theratechnologies Inc (2) | 2.12 | SEDAR Preliminary Short Form Prospectus819 | SEDAR Preliminary Short Form Prospectus |
| 2023-12-21 16:22 | CC:TH | Theratechnologies Inc (2) | 2.12 | News Release200 | Theratechnologies files preliminary shelf prospectus |
| 2023-12-13 11:31 | CC:TH | Theratechnologies Inc (2) | 2.13 | News Release200 | Theratechnologies' Trogarzo receives push-loading ok |
| 2023-10-31 14:45 | CC:TH | Theratechnologies Inc (2) | 1.27 | News Release200 | Theratechnologies closes $25-million (U.S.) in financings |
| 2023-10-27 20:16 | CC:TH | Theratechnologies Inc (2) | 1.34 | Prospectus Approved3 | Theratechnologies to list 12.5 million more shares |
| 2023-10-26 10:19 | CC:TH | Theratechnologies Inc (2) | 1.71 | News Release200 | Theratechnologies prices $12.5M (U.S.) public offering |
| 2023-10-25 16:40 | CC:TH | Theratechnologies Inc (2) | 1.71 | News Release200 | Theratechnologies arranges public offering, placement |
| 2023-10-24 09:36 | CC:TH | Theratechnologies Inc (2) | 1.93 | News Release200 | Theratechnologies to lay off 25 R&D staff |
| 2023-10-19 10:36 | CC:TH | Theratechnologies Inc (2) | 2.26 | News Release200 | Theratechnologies talks Trogarzo cost benefits |
| 2023-10-16 13:30 | CC:TH | Theratechnologies Inc (2) | 2.40 | News Release200 | Theratechnologies finalizes amendments to Marathon loan |
| 2023-10-13 09:25 | CC:TH | Theratechnologies Inc (2) | 2.48 | News Release200 | Theratechnologies details tesamorelin data at ID Week |
| 2023-10-13 09:16 | CC:TH | Theratechnologies Inc (2) | 2.48 | News Release200 | Theratechnologies talks Trogarzo IM study results |
| 2023-10-12 10:09 | CC:TH | Theratechnologies Inc (2) | 2.48 | News Release200 | Theratechnologies doses 1st patient in part 3 of trial |
| 2023-10-04 10:23 | CC:TH | Theratechnologies Inc (2) | 2.65 | News Release200 | Theratechnologies receives Jan. 22 F8 sBLA goal date |
| 2023-09-28 08:37 | CC:TH | Theratechnologies Inc (2) | 2.82 | In the News525 | Globe says Theratechnologies kept at "sector perform" |
| 2023-09-26 11:21 | CC:TH | Theratechnologies Inc (2) | 2.29 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-09-26 10:23 | CC:TH | Theratechnologies Inc (2) | 2.29 | News Release200 | Theratechnologies loses $746,000 (U.S.) in Q3 2023 |
| 2023-09-26 09:52 | CC:TH | Theratechnologies Inc (2) | 2.81 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-09-26 09:50 | CC:TH | Theratechnologies Inc (2) | 2.81 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-09-26 09:50 | CC:TH | Theratechnologies Inc (2) | 2.81 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-09-26 09:50 | CC:TH | Theratechnologies Inc (2) | 2.81 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-09-26 09:50 | CC:TH | Theratechnologies Inc (2) | 2.81 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-09-26 09:49 | CC:TH | Theratechnologies Inc (2) | 2.81 | SEDAR Interim MD & A813 | SEDAR Interim MD & A |
| 2023-09-25 10:16 | CC:TH | Theratechnologies Inc (2) | 2.91 | News Release200 | Theratechnologies amends terms of Marathon loan |
| 2023-09-25 10:07 | CC:TH | Theratechnologies Inc (2) | 2.91 | News Release200 | Theratechnologies files tesamorelin formulation sBLA |
| 2023-09-18 16:30 | CC:TH | Theratechnologies Inc (2) | 2.98 | News Release200 | Theratechnologies to release Q3 results Sept. 26 |
| 2023-09-05 14:01 | CC:TH | Theratechnologies Inc (2) | 1.43 | News Release200 | Theratechnologies has cash of $22.9M (U.S.) at Aug. 31 |
| 2023-08-30 11:04 | CC:TH | Theratechnologies Inc (2) | 1.29 | News Release200 | Theratechnologies begins sudocetaxel trial enrolment |
| 2023-07-31 13:15 | CC:TH | Theratechnologies Inc (2) | 0.77 | News Release200 | Theratechnologies completes 1:4 share rollback |
| 2023-07-28 16:56 | CC:TH | Theratechnologies Inc (1) | 0.77 | News Release200 | Theratechnologies amends credit agreement with Marathon |
| 2023-07-27 18:11 | CC:TH | Theratechnologies Inc (1) | 0.75 | Rollback291 | Theratechnologies 1:4 rollback |
| 2023-07-21 10:22 | CC:TH | Theratechnologies Inc | 0.95 | News Release200 | Theratechnologies' Littlejohn resigns as director |
| 2023-07-20 13:00 | CC:TH | Theratechnologies Inc | 1.06 | News Release200 | Theratechnologies arranges 1:4 share rollback |
| 2023-07-12 10:01 | CC:TH | Theratechnologies Inc | 1.16 | News Release200 | Theratechnologies loses $10.01-million (U.S.) in Q2 |
| 2023-07-12 08:16 | CC:TH | Theratechnologies Inc | 1.26 | SEDAR Interim Financial Statements812 | SEDAR Interim Financial Statements |
| 2023-07-12 08:16 | CC:TH | Theratechnologies Inc | 1.26 | SEDAR MD & A815 | SEDAR MD & A |
| 2023-06-29 12:59 | CC:TH | Theratechnologies Inc | 1.16 | News Release200 | Theratechnologies to release Q2 2023 results July 12 |
| 2023-06-22 11:22 | CC:TH | Theratechnologies Inc | 1.20 | News Release200 | Theratechnologies draws down $20M (U.S.) on facility |
| 2023-06-14 17:12 | CC:TH | Theratechnologies Inc | 1.27 | Miscellaneous270 | Theratechnologies 5.75% notes to be delisted from TSX |
| 2023-06-13 15:58 | CC:TH | Theratechnologies Inc | 1.24 | Miscellaneous270 | Theratechnologies special settlement |
| 2023-06-12 12:12 | CC:TH | Theratechnologies Inc | 1.23 | News Release200 | Theratechnologies to hold investor call June 13 |
| 2023-06-02 12:29 | CC:TH | Theratechnologies Inc | 1.16 | News Release200 | Theratechnologies to resume phase 1 PDC clinical trial |
| 2023-05-25 18:01 | CC:TH | Theratechnologies Inc | 1.26 | News Release200 | Theratechnologies to present phase 1 sudocetaxel data |
| 2023-05-23 11:06 | CC:TH | Theratechnologies Inc | 1.22 | Miscellaneous270 | Theratechnologies special settlement |
| 2023-05-19 17:32 | CC:TH | Theratechnologies Inc | 1.22 | SEDAR Early Warning Report807 | SEDAR Early Warning Report |
| 2023-05-19 17:27 | CC:TH | Theratechnologies Inc | 1.22 | News Release200 | Theratechnologies investor Soleus acquires 7,000 shares |
| 2023-05-09 16:37 | CC:TH | Theratechnologies Inc | 1.28 | News Release200 | Theratechnologies holders elect nine directors at AGM |
| 2023-05-04 11:03 | CC:TH | Theratechnologies Inc | 1.22 | News Release200 | Theratechnologies details Trogarzo data at ACTHIV |